Ensign Peak Advisors Inc Boosts Stock Position in Mettler-Toledo International, Inc. $MTD

Ensign Peak Advisors Inc lifted its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 10.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 112,433 shares of the medical instruments supplier’s stock after purchasing an additional 10,580 shares during the quarter. Ensign Peak Advisors Inc owned about 0.55% of Mettler-Toledo International worth $132,077,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of MTD. Brooklyn Investment Group grew its holdings in shares of Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 10 shares during the period. Sax Wealth Advisors LLC lifted its position in Mettler-Toledo International by 2.8% in the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock valued at $437,000 after buying an additional 10 shares during the last quarter. Penserra Capital Management LLC boosted its stake in Mettler-Toledo International by 10.7% during the second quarter. Penserra Capital Management LLC now owns 114 shares of the medical instruments supplier’s stock worth $133,000 after buying an additional 11 shares during the period. Horizon Investments LLC increased its position in shares of Mettler-Toledo International by 4.2% during the first quarter. Horizon Investments LLC now owns 299 shares of the medical instruments supplier’s stock valued at $353,000 after acquiring an additional 12 shares during the last quarter. Finally, MV Capital Management Inc. lifted its holdings in shares of Mettler-Toledo International by 50.0% in the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 12 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Up 0.6%

Shares of Mettler-Toledo International stock opened at $1,404.89 on Thursday. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,471.06. The company has a 50 day moving average of $1,341.35 and a 200 day moving average of $1,256.38. The company has a market capitalization of $28.70 billion, a P/E ratio of 35.58, a P/E/G ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period last year, the firm earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently weighed in on MTD shares. Wells Fargo & Company lifted their target price on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. JPMorgan Chase & Co. boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday, October 9th. Citigroup lifted their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Finally, Barclays increased their target price on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a report on Monday, November 10th. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $1,406.50.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 1,895 shares of Mettler-Toledo International stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,696,789.76. The trade was a 26.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider La Guerroniere Marc De sold 6,880 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the transaction, the insider directly owned 187 shares in the company, valued at approximately $271,150. This trade represents a 97.35% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 11,249 shares of company stock worth $16,338,723. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.